Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Current Taxes (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Current Taxes data on record, last reported at $5000.0 in Q1 2025.

  • For Q1 2025, Current Taxes changed N/A year-over-year to $5000.0; the TTM value through Mar 2025 reached $5000.0, changed N/A, while the annual FY2024 figure was $211000.0, 29.9% down from the prior year.
  • Current Taxes reached $5000.0 in Q1 2025 per ZBIO's latest filing, down from $211000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $301000.0 in Q4 2023 and bottomed at $5000.0 in Q1 2025.
  • Average Current Taxes over 3 years is $172333.3, with a median of $211000.0 recorded in 2024.
  • The widest YoY moves for Current Taxes: up 29.9% in 2024, down 29.9% in 2024.
  • A 3-year view of Current Taxes shows it stood at $301000.0 in 2023, then dropped by 29.9% to $211000.0 in 2024, then crashed by 97.63% to $5000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $5000.0 in Q1 2025, $211000.0 in Q4 2024, and $301000.0 in Q4 2023.